tradingkey.logo

Amgen climbs after upbeat 2026 profit forecast

ReutersFeb 4, 2026 11:49 AM

Shares of drugmaker Amgen AMGN.O rise 1.5% to $343.58 premarket

Company forecasts annual adj. profit per share between $21.60 and $23, above analysts' average estimate of $22.09 - data compiled by LSEG

AMGN reports Q4 adj. profit of $5.29/shr vs estimate of $4.73/shr

"While we are encouraged by strong performance from several products, including Prolia, Evenity, Repatha, and Vectibix, the beat was also aided by approximately $250 million in inventory build in the fourth quarter across the portfolio" - William Blair analyst Matt Phipps

Quarterly revenue of $9.9 billion beats analysts' expectation of $9.5 billion

Shares up 3.5% in 2025

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI